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12.10.003Abstract Amino acid changes due to non-synonymous variation are included as annotations for
individual proteins in UniProtKB/Swiss-Prot and RefSeq which present biological data in a pro-
tein- or gene-centric fashion. Unfortunately, proteome-wide analysis of non-synonymous single-
nucleotide variations (nsSNVs) is not easy to perform because information on nsSNVs and func-
tionally important sites are not well integrated both within and between databases and their search
engines. We have developed SNVDis that allows evaluation of proteome-wide nsSNV distribution
in functional sites, domains and pathways. More speciﬁcally, we have integrated human-speciﬁc
data from major variation databases (UniProtKB, dbSNP and COSMIC), comprehensive sequence
feature annotation from UniProtKB, Pfam, RefSeq, Conserved Domain Database (CDD) and
pathway information from Protein ANalysis THrough Evolutionary Relationships (PANTHER)
and mapped all of them in a uniform and comprehensive way to the human reference proteome pro-
vided by UniProtKB/Swiss-Prot. Integrated information of active sites, pathways, binding sites,
domains, which are extracted from a number of different sources, provides a detailed overview
of how nsSNVs are distributed over the human proteome and pathways and how they intersect with
functional sites of proteins. Additionally, it is possible to ﬁnd out whether there is an over- or
under-representation of nsSNVs in speciﬁc domains, pathways or user-deﬁned protein lists. The
underlying datasets are updated once every 3 months. SNVDis is freely available at http://hive.bio-
chemistry.gwu.edu/tool/snvdis.mder R).
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One of the most common uses of high-throughput sequencing
is single-nucleotide variations (SNVs) discovery, resulting in
increasingly large numbers of SNVs. Variations that results
in a different amino acid belong to the non-synonymous sin-
gle-nucleotide variation (nsSNV) category. The three major
publicly-available resources that compile such variation data
are UniProtKB [1], dbSNP [2] and Catalog Somatic Mutations
in Cancer (COSMIC) (http://www.sanger.ac.uk/genetics/CGP/
cosmic/). Projects like the 1000 Genomes Project [3] arecademy of Sciences and Genetics Society of China. Production and hosting
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databases will continue integrating other large-scale SNV data
as they become available.
Variation data in itself has very little biological meaning. Inte-
gration of complimentary information on sequence features such
as those available from UniProtKB, RefSeq [4], Pfam [5], Con-
served Domain Database (CDD) [6] and Protein ANalysis
THrough Evolutionary Relationships (PANTHER) [7] is neces-
sary to analyze the effects of these variations on active sites, binding
sites, protein domains, glycosylation sites, pathways and overall
protein and proteome function. Several services are available to
identify the effect of nsSNVs on individual protein function which
is done mainly through sequence conservation analysis and/or
through mapping of sequence and structure features to individual
proteins [8–10]. To the best of our knowledge none of them allow
proteome-wide analysis of integrated data similar to the work on
proteome-wideanalysis on the effect ofnsSNVsonN-glycosylation
sites [11]. SNVDis is a web tool that addresses this by integrating
variation data with curated sequence feature annotations in a
protein-centric fashion. More speciﬁcally, the tool can be used
to ﬁnd nsSNVs inside speciﬁc sites (active and binding), protein
domains and pathways in user-deﬁned set of proteins or in the
entire proteome. SNVDis can also be used to statistically evalu-
ate if there is an over- or under-representation of nsSNVs in spe-
ciﬁc domains and pathways and user deﬁned protein sets.
Methods
Architecture
All the datasets required for the analysis are collected, updated
and stored, on a regular basis, in a database in the High-per-
formance Integrated Virtual Environment (HIVE) server
[12]. The datasets are organized in a database with all data
mapped to nsSNV ids (Figure 1).
Datasets
The complete human proteome is obtained from UniProtKB/
Swiss-Prot using the complete proteome keyword. Then sSNVFigure 1 SNVDis data integration model
Additional data can be easily integrated into the database if they are mvariation data is extracted fromUniProtKB/Swiss-Prot, RefSeq
which provides dbSNP data and COSMIC. Information on
pathways is collected from PANTHER, protein domain infor-
mation is obtained from Pfam and information on active and
binding sites and N-linked glycosylation sites is collected from
UniProtKB and CDD. Apart from UniProtKB data which is
downloaded using UniProtJAPI, the rest of the datasets are ex-
tracted from ﬁles provided in ftp servers of each database.
Position mapping
Since both Pfam and PANTHER provide their datasets
mapped to UniProtKB, there is no need to perform any addi-
tional mapping. In contrast, ID mapping [13] is necessary in
the case of dbSNP, CDD and COSMIC data. Pairs already
mapped between these databases are extracted from ID map-
ping ﬁles and the Needleman-Wunsch algorithm [14] is used
to align sequence pairs to conﬁrm mappings.
Expected nsSNVs
The tool returns the number of nsSNVs that are present inside
a domain, site (active, binding or N-glycosylation) or a group
of proteins and also provides the number of nsSNVs that
should be expected on the assumption of uniform distribution.
The number of expected nsSNVs is calculated using the follow-
ing equation:
Sexpected ¼ Sinput Linput
Lquery
where LinputSinput and Lquery depend on the type of the analysis.
In the case of domains or custom domains analysis, sinput is the
number of nsSNVs found inside the domain. Linput is the sum
of sizes of that domain found in various proteins and Lquery
is the sum of sizes of these proteins that contain the domain.
In the case of protein set analysis, Sinput is the number of
nsSNVs found inside the proteins of this protein set. Linput is
the sum of sizes of all the proteins in this protein set and
Lquery is the size of the entire proteome. In the case of site anal-
ysis, Sinput is the number of nsSNVs found inside the sites. Linputapped to any sequence database accession numbers or identiﬁers.
124 Genomics Proteomics Bioinformatics 11 (2013) 122–126is the sum of sizes of these sites found in various proteins and
Lquery is the sum of sizes of these proteins that contain these
sites. P value is calculated based on methodology described
earlier [15].
Computational environment
HIVE provides computational infrastructure for storage and
analysis for this project. Resources include two Dell servers,
an integrated computational powerhouse private cloud,
10Gb 48-port Ethernet switch and cloud control servers.
Results and discussion
Users can perform queries using different combinations of
nsSNV datasets from UniProtKB, dbSNP, COSMIC and
NCI-60 cell lines and analyze their effect on active sites, bind-
ing sites, N-linked glycosylation sites, protein domains and
pathways. As a ﬁrst step, the user selects the sources of nsSNV
data and the UniProtKB accessions that are included in the
search. The accession numbers can only be a subset of Uni-
ProtKB/Swiss-Prot’s human proteome set or the entire human
proteome. At the time of writing of this paper, there were al-
most 780,000 nsSNVs collected from COSMIC (including
NCI-60), UniProtKB and dbSNP. Out of them, about
670,000 were mapped successfully to UniProtKB/Swiss-Prot
human proteome. Finally, due to duplications inside individ-
ual datasets and between different data sources, more than
450,000 distinct variations were mapped to the human prote-
ome. Distinct variations are deﬁned as those that occur at dif-
ferent positions or lead to different amino acid changes.
Analysis of nsSNVs in functional sites
Functionally important amino acid sites such as active sites
and binding sites are based on manually-curated annotations
available from UniProt [1] and CDD [6]. In Figure 2A, we
can easily see that the three data sources from which we get
our variation data, namely UniProtKB, dbSNP and COSMIC,
have very different coverage. In fact, in the example of active
sites there are no nsSNVs that come from all three sourcesFigure 2 Distribution of nsSNVs
A. The total number of nsSNVs from different databases that fall insi
number of nsSNVs that can be found inside binding site regions deﬁned
a large percentage of unique entries.and the overlap of COSMIC with UniProtKB and dbSNP is
quite low (Figure 2A), while there is some overlap for binding
sites (Figure 2B). We intend to continue including other
sources of high-quality variation data based on user requests.
One of the major advantages of this service is the ability to
query and analyze integrated datasets. For example, integrat-
ing active site and binding site information from the two major
sources of curated sequence features (UniProtKB/Swiss-Prot
and CDD) with data from three variation databases can
quickly provide a comprehensive view of the potential effect
of variation on protein function. For example, we ﬁnd 559 en-
zymes which possibly are inactive in certain populations or
cells due to variations in their active site. Based on Uni-
ProtKB/Swiss-Prot keyword and Gene Ontology analysis, en-
zymes involved in carbohydrate and lipid metabolism are over-
represented in the dataset while proteins involved in transcrip-
tion and transport are highly under-represented. Clustering of
these 559 enzymes reveals that kinases and proteases form the
two largest protein families that are impacted by nsSNVs on
their active sites.
Analysis of nsSNVs in protein domains
Users can also ﬁnd which protein domains and/or pathways
have signiﬁcantly higher numbers of nsSNVs. Pfam domains
Trypsin (PF00089), Tyrosine kinase (PF07714) and SET
(PF00856) are examples of such domains with signiﬁcantly
higher than expected numbers of nsSNVs. Users can select
to retrieve nsSNV distribution results for all the PFAM do-
mains by selecting no P value cut-off, or alternatively they
can select a stringent P value cut-off to retrieve only those do-
mains that have signiﬁcantly higher than expected number of
nsSNVs. Users can also select to investigate just one domain
by using the ‘Select a domain’ option.Analysis of nsSNVs in pathways
The tool makes it easy to ﬁnd pathways that have signiﬁcantly
higher numbers of nsSNVs than what is expected. Examples of
such pathways include p53 pathways and ubiquitin protea-
some pathway. Users can also have a list of accessions,de active sites as annotated by UniProt or CDD. B. Similarly, the
by UniProt or CDD. Notice that in both cases, all databases have
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and check to see if there is an over- or under-representation
of nsSNVs in their dataset. For example, the user can perform
a search in the UniProt database to retrieve all proteins in-
volved in Alzheimer’s disease and they can then upload these
accessions to see if there are signiﬁcantly higher or lower num-
bers of nsSNVs in these proteins compared to the normal dis-
tribution expected. From the results page users can also
explore the variations further through hyperlinks to databases
such as UniProt, RefSeq and dbSNP.
Analysis of nsSNVs in user-deﬁned regions of proteins
Users may have a list of proteins with regions in these proteins;
such as domain boundaries that are of speciﬁc interest. Such a
dataset consisting of UniProtKB accession (one per line) fol-
lowed by comma separated amino acid ranges (e.g., Q8WXI7,
1–10,000, and 10,001–20,000) can be investigated to see if there
are more nsSNVs in speciﬁc regions of the proteins.
Usage and utility
We provide an elegant yet simple tool that allows proteome-
wide analysis of variation data. Although analysis of single
proteins is possible using this tool, the main emphasis of the
tool is to provide a comprehensive view of the effect of nsSNV
on the entire proteome or pathways or all proteins that have a
speciﬁc domain. The tool is ﬂexible and allows users to deﬁne
which proteins constitute the proteome or pathway. Users can
also deﬁne custom domain boundaries. Below are some use-
cases that highlight several tool features.
Identify proteins in the human proteome that has loss of
glycosylation sites due to nsSNVs
The glycoproteome is variable. It is clear that to get a compre-
hensive view of the glycoproteome,we need to factor in gain/loss
of glycosylation sites due to SNVs [11]. Such novel sites can be
present in some populations or in cancer cells. List of proteins
that are affected at the N-linked glycosylation site due to varia-
tion can be retrieved by selecting UniProtKB/Swiss-Prot prote-
ome and all the variation datasets shown in the tool home page
and clicking ‘Submit’. This will take the user to the next page
which has several types of nsSNVanalysis options. In the ‘Func-
tional sites’ analysis box, select ‘N-linked glycosylation sites’
and then unclick ‘or not’ check box and then select ‘Submit’.
The results page will be generated which provides tables and
graphical representation of the sites, proteins and the type of
amino acids (polar, negatively charged, neutral and positively
charged) involved in the variation.
Retrieve proteins with nsSNVs at active sites or binding sites
Users can choose to ﬁnd out the effect in the entire proteome
or just a set of proteins (for example, a set of proteins found to
be down-regulated in some experiment). Such a list of proteins
can be retrieved by following the same workﬂow as described
above except, instead of selecting ‘N-linked glycosylation
sites’, the user would need to select ‘Active sites’ and/or ‘Bind-
ing sites’. By merging data from several extant databases and
using the tool, we ﬁnd that there are 934 unique nsSNVs that
occur at the active sites of 559 unique proteins. Follow uppathway and functional analysis using Ingenuity Pathway Anal-
ysis (IPA) tools, a web based interface for Ingenuity Knowledge
Base (Ingenuity Systems, http://www.ingenuity.com) shows
several pathways over- or under-represented in the active site
nsSNV dataset, with the most signiﬁcantly affected pathways in-
volved in carbohydrate metabolism. Disease-propensity analysis
shows a signiﬁcant over-representation of glycogen storage dis-
eases (GSD) and various neurodegenerative diseases. Such results
are interesting because in follow-up studies one can try to see
what products or substrates would be altered if such a variation
was to be found. Genotyping chips, which can scan thousands of
people, can be used to see if any of these variations do exist
and if such variations lead to metabolic disorders or other phe-
notypes. These observations are useful in the planning and exe-
cution of future studies relating active/binding site nsSNVs to
protein dysfunction and human disease. These examples pro-
vide data that can be used to generate simple hypotheses, dem-
onstrating predictive utility of this method.
Determine if a particular Pfam domain has over-representation
of nsSNVs
To perform this analysis, user selects UniProtKB/Swiss-Prot pro-
teome and all the variation datasets in the tools home page and
clicks ‘Submit’. This will take the user to the next page which has
several types of nsSNV analysis options. In the ‘Protein domains’
analysis box, click on ‘Select a domain’ and enter ‘PF00856’. For
this domain (SET domain), we do see that there is an over-repre-
sentationof the nsSNVs.This could be due to the fact that this pro-
tein has been heavily researched, or it could be also due to the fact
that this protein is indeed prone to variation. Additional research
would be necessary to investigate these hypotheses.
Enrichment analysis of nsSNVs in custom protein/gene sets
Given a list of proteins/genes that are up-regulated in an exper-
iment, user can ﬁnd out if these genes are more or less prone to
nsSNV compared to the rest of the genes from humans. Such
analysis can be done by selecting UniProtKB/Swiss-Prot pro-
teome and all the variation datasets in the home page for the
tools and clicking ‘Submit’. This will take the user to the next
page which has several types of nsSNV analysis that the user
can perform. In the ‘Protein sets’ analysis box, select ‘Select
a pathway or provide your set’ and then from the pull-down
menu select ‘Provide your own pathway’ and paste UniProtKB
accession numbers and click on ‘Submit’. The results page pro-
vides tables and graphical representation of the sites, variation
and proteins and statistical evaluation of over- or under-repre-
sentation of the nsSNV in the dataset. In this workﬂow, user
can also choose to use one single protein, although informa-
tion on one single protein can also be obtained directly by
going to the respective databases. The only additional infor-
mation in this case would be the statistical evaluation of the
distribution of the nsSNVs in that particular protein.
Enrichment analysis of nsSNVs in user-deﬁned protein
boundaries
Given a list of proteins and regions within these proteins, the
‘Custom domain’ functionality can be used to ﬁnd out if these
regions are more or less prone to nsSNVs. For example, this
functionality can be used to determine if there is more varia-
tion in the beta-sheets or loops.
126 Genomics Proteomics Bioinformatics 11 (2013) 122–126There are many more such use-cases which are being com-
piled and provided on our website. Although the service re-
turns tables with details on each nsSNV, there are also pre-
computed datasets available from the website. These datasets
were generated based on user requests. Currently the following
ﬁles are available: all nsSNVs in the human proteome, all
nsSNVs in the human proteome that lead to gain of N-linked
glycosylation motif and all nsSNVs in the human proteome
that lead to loss of N-linked glycosylation.
Conclusion
The tool provides a list of proteins that are affected by varia-
tions in annotated functional sites. Such integration of varia-
tion data with functional annotation can allows users to
perform proteome-wide analysis and hypothesis generation
as described in the use-cases above. Although the main focus
of the tool is not to report if a variation in a single gene/protein
is deleterious, this type of analysis can still be performed to
estimate if the amount of variation identiﬁed in the protein
is over- or under-represented when compared to the rest of
the proteome.
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